atezolizumab,olaparib
roche,merck,astrazeneca
['brca', 'atezo', 'breast', 'olaparib']
check it out #aacr23 poster collab w/ (dr. pat lorusso) &amp; , discusses efficacy of the parpi olaparib as monotherapy vs. in combination with pd-l1 inhibitor atezolizumab in pts with brcamt advanced #breastcancer (#etctn 10020). 
Official Twitter account of NCI's Cancer Therapy Evaluation Program, providing updates to our trials research community. Part of @NIH. Privacy: https://t.co/9Aox3geiD8